Inhibikase Therapeutics has developed protein kinase inhibitors for the treatment of infectious disease and cancer. The Company’s infectious disease products are the first small molecules capable of treating bacterial infections, viral infections and certain cancers through a common mechanism of action with a low likelihood of resistance. The Company’s products include antiviral treatments for respiratory, kidney, liver and brain infections.